Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in Days.
The item "Days-of-Sales-Outstanding" stands at 58.44 days as of 09/30/2025.
As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Days of Sales Outstanding" stands at 58.44 Days. This represents an increase of 0.29 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -0.7714 percent compared to the value the year prior.
The 1 year change in percent is -0.7714.
The 3 year change in percent is -21.91.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Days of Sales Outstanding | 905,699,262,464.00 |
![]() | Johnson & Johnson - Days of Sales Outstanding | 486,508,953,600.00 |
![]() | AbbVie Inc - Days of Sales Outstanding | 399,570,305,024.00 |
![]() | Roche Holding AG - Days of Sales Outstanding | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Days of Sales Outstanding | 280,205,508,085.11 |